While there is currently no available cure for <i>NR2E3</i>-related retinopathies, there are a number of emerging therapeutic strategies under investigation, including the use of viral gene therapy and gene editing, that have shown promise for the future treatment of patients with <i>NR2E3</i> variants and other inherited retinal diseases. This evidence concerns the gene NR2E3 and retinal disorder.